These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 21976245)

  • 81. Application of proteomics to graft-versus-host disease: from biomarker discovery to potential clinical applications.
    Presland RB
    Expert Rev Proteomics; 2017 Nov; 14(11):997-1006. PubMed ID: 28974115
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Prevention of graft-vs.-host disease.
    Rezvani AR; Storb RF
    Expert Opin Pharmacother; 2012 Aug; 13(12):1737-50. PubMed ID: 22770714
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Role of the intestinal mucosa in acute gastrointestinal GVHD.
    Peled JU; Hanash AM; Jenq RR
    Blood; 2016 Nov; 128(20):2395-2402. PubMed ID: 27856471
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Study protocol: Close Assessment and Testing for Chronic Graft-vs.-Host disease (CATCH).
    Pidala J; Carpenter PA; Onstad L; Pavletic SZ; Hamilton BK; Chen GL; Farhadfar N; Hall M; Lee SJ
    PLoS One; 2024; 19(5):e0298026. PubMed ID: 38753616
    [TBL] [Abstract][Full Text] [Related]  

  • 85. GVHD: a continuing barrier to the safety of allogeneic transplantation.
    Reddy P; Arora M; Guimond M; Mackall CL
    Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):162-8. PubMed ID: 19147099
    [No Abstract]   [Full Text] [Related]  

  • 86. CT and MRI findings in sclerodermatous chronic graft vs. host disease.
    Dumford K; Anderson JC
    Clin Imaging; 2001; 25(2):138-40. PubMed ID: 11483427
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Cutaneous graft-versus-host disease].
    Cho A; Just U; Knobler R
    Hautarzt; 2018 Feb; 69(2):109-115. PubMed ID: 29344728
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
    Saad A; de Lima M; Anand S; Bhatt VR; Bookout R; Chen G; Couriel D; Di Stasi A; El-Jawahri A; Giralt S; Gutman J; Ho V; Horwitz M; Hsu J; Juckett M; Kharfan-Dabaja MA; Loren A; Meade J; Mielcarek M; Moreira J; Nakamura R; Nieto Y; Roddy J; Satyanarayana G; Schroeder M; Tan CR; Tzachanis D; Burn J; Pluchino L
    J Natl Compr Canc Netw; 2020 May; 18(5):599-634. PubMed ID: 32519831
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Recent advances in ocular graft-versus-host disease.
    Cheng X; Huang R; Huang S; Fan W; Yuan R; Wang X; Zhang X
    Front Immunol; 2023; 14():1092108. PubMed ID: 36761771
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Cutaneous Graft-Versus-Host Disease: Diagnosis and Treatment.
    Strong Rodrigues K; Oliveira-Ribeiro C; de Abreu Fiuza Gomes S; Knobler R
    Am J Clin Dermatol; 2018 Feb; 19(1):33-50. PubMed ID: 28656563
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Have we made progress in the management of chronic graft-vs-host disease?
    Lee SJ
    Best Pract Res Clin Haematol; 2010 Dec; 23(4):529-35. PubMed ID: 21130418
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Chronic graft-versus-host disease. Part I: Epidemiology, pathogenesis, and clinical manifestations.
    Baumrin E; Loren AW; Falk SJ; Mays JW; Cowen EW
    J Am Acad Dermatol; 2024 Jan; 90(1):1-16. PubMed ID: 36572065
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Management of acute graft-versus-host disease in children.
    Carpenter PA; Macmillan ML
    Pediatr Clin North Am; 2010 Feb; 57(1):273-95. PubMed ID: 20307721
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Current Definitions and Clinical Implications of Biomarkers in Graft-versus-Host Disease.
    Bidgoli A; DePriest BP; Saatloo MV; Jiang H; Fu D; Paczesny S
    Transplant Cell Ther; 2022 Oct; 28(10):657-666. PubMed ID: 35830932
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Progress in the management of chronic GVHD insights into novel therapies to treat and manage GVHD lasting longer than 12 Months.
    Flowers MED
    Best Pract Res Clin Haematol; 2021 Mar; 34(1):101253. PubMed ID: 33762107
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Glucocorticoid-refractory acute graft-versus-host disease.
    Pidala J; Anasetti C
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1504-18. PubMed ID: 20096359
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Problem-solving in clinical practice: breathing difficulty and muscle weakness following allogeneic haematopoietic stem cell transplantation.
    Albulushi B; Thabet F; Alshahwan S; Elborai Y; Alkhayat N; Alshahrani M; Tabarki B
    Arch Dis Child Educ Pract Ed; 2021 Apr; 106(2):125-128. PubMed ID: 32900776
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A new standard treatment for prevention of GvHD after HCT?
    Choi SW
    Lancet Haematol; 2019 Mar; 6(3):e113-e114. PubMed ID: 30824035
    [No Abstract]   [Full Text] [Related]  

  • 99. Patient-reported symptom burden of chronic graft versus host disease: a systematic literature review.
    Csanádi M; Ágh T; Farkas-Ráduly S; Gros B; Tapprich C; Trudeau JJ; Lipton JH; Mattsson J
    Expert Rev Hematol; 2020 Oct; 13(10):1119-1130. PubMed ID: 32865071
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Updates in chronic graft-versus-host disease.
    Hamilton BK
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):648-654. PubMed ID: 34889364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.